Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.9800
0.00 (0.00%)
Sep 18, 2026, 1:51 PM HKT

HKG:2348 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,2931,1661,158905.83811.68577.74
Short-Term Investments
-227.91242.3410788.844.3
Trading Asset Securities
299.49410.49207.14160.87181.36208.18
Cash & Short-Term Investments
1,5921,8051,6081,1741,082830.22
Cash Growth
-1.78%12.26%36.98%8.49%30.31%-13.71%
Accounts Receivable
252.31265.22267.89322402.85346.78
Other Receivables
-----20.8
Receivables
252.31265.22267.89322402.85367.58
Inventory
209.03215.44308.24211.11241.75203.48
Prepaid Expenses
232.488.137.3813.414.9915.5
Other Current Assets
--11-2.5894.26
Total Current Assets
2,2862,2942,2021,7201,7441,511
Property, Plant & Equipment
1,1431,1741,2281,2171,3011,143
Long-Term Investments
36.4820202025.3587.25
Goodwill
241.16241.16241.16241.16241.16241.16
Other Intangible Assets
278.77128.69164.77160.31109.4897.99
Long-Term Deferred Tax Assets
0.194.915.4718.986.865.75
Long-Term Deferred Charges
-143.38136.16128185.54189.03
Other Long-Term Assets
2.423.5711.0810.37.5614.36
Total Assets
3,9884,0094,0093,6233,6733,340

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
210.38173.78221.56162.16224.07143.21
Accrued Expenses
-9599.34108.27171.28156.94
Short-Term Debt
4.4877.4829.86120.066.4321.01
Current Portion of Leases
--1.160.361.530.98
Current Income Taxes Payable
16.446.482.645.238.6515.5
Current Unearned Revenue
-10.332.7317.929.6614.45
Other Current Liabilities
193.95130.94167.35214.96490.43345.01
Total Current Liabilities
425.25493.97554.6668.94932.06697.1
Long-Term Leases
--3.70.10.441.53
Long-Term Unearned Revenue
3.182.883.36-0.30.6
Long-Term Deferred Tax Liabilities
127.28127.51120.9594.3889.9866.87
Other Long-Term Liabilities
-----175.6
Total Liabilities
555.71624.36682.61763.431,023941.7

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
80.7380.680.5380.4680.3980.37
Additional Paid-In Capital
-107.39105.95104.41103.09102.7
Retained Earnings
-3,1873,1022,6492,4362,174
Comprehensive Income & Other
3,35110.1735.521.2422.5123.2
Total Common Equity
3,4323,3853,3242,8552,6422,381
Minority Interest
--2.44.587.9117.15
Shareholders' Equity
3,4323,3853,3272,8592,6502,398
Total Liabilities & Equity
3,9884,0094,0093,6233,6733,340

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
4.4877.4834.72120.538.4123.52
Net Cash (Debt)
1,5881,7271,5731,0531,073806.7
Net Cash Growth
-1.50%9.81%49.36%-1.89%33.06%-15.90%
Net Cash Per Share
1.061.151.040.700.710.53
Filing Date Shares Outstanding
1,5041,5031,5021,5001,4991,498
Total Common Shares Outstanding
1,5041,5031,5021,5001,4991,498
Working Capital
1,8611,8001,6481,051811.94813.93
Book Value Per Share
2.282.252.211.901.761.59
Tangible Book Value
2,9123,0152,9182,4532,2912,042
Tangible Book Value Per Share
1.942.011.941.641.531.36
Buildings
-812.11788.38584.74531.28243.42
Machinery
-668.53634.79485.74721.4624.16
Construction In Progress
-56.8885.57356.9495.14675.2
Leasehold Improvements
-0.046.686.666.646.59